Chronix Biomedical Obtains $1,741,389 New Round

  • Feed Type
  • Date
    9/15/2010
  • Company Name
    Chronix Biomedical
  • Mailing Address
    1735 North First Street San Jose, CA 95112
  • Company Description
    Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status. The company plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany.
  • Website
    http://www.chronixbiomedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,741,389
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed